Zogenix, Inc. (NASDAQ:ZGNX)

Top Analyst Upgrades and Downgrades: AECOM, Ciena, Evoqua Water Tech, Funko, GlaxoSmithKline, Square and Many More

Stocks were directionless on Monday, with most Americans slowly trickling back into the office after an extended Thanksgiving break. Still, the major U.S. indexes remain close to all-time highs and ...
Read Full Story »

Why Zogenix Shares More Than Doubled

Zogenix Inc. (NASDAQ: ZGNX) saw its shares more than double early on Friday after the company reported positive top-line results from its most recent late-stage trial in the treatment of ...
Read Full Story »
white pills

Why This Analyst Sees Huge Upside for Valeant and 2 More Specialty Pharmas

We have written at length on the beating the biotechs have endured. Another sub-sector that has been right alongside for the trip to the Wall Street woodshed has been specialty ...
Read Full Story »
Money and plant

4 Analyst Stock Picks With 50% to 100% Upside Potential

As we head into a huge stretch of earnings, many investors are wondering if a fourth-quarter rally is really in the cards, or whether we will start hitting lower higher ...
Read Full Story »
179378515

5 Highly Unusual Stock Moves of the Past Week

The bull market may have seen an interruption this past week, but stocks are still very close to all-time highs and this bull market is now six years old. It ...
Read Full Story »
biotech

The Gamble That Did Not Pay Off

Zogenix Inc. (NASDAQ: ZGNX) announced an agreement for the sale of its Zohydro ER (hydrocodone bitartrate) business to Pernix for $100 million. This transaction will be composed of $30 million ...
Read Full Story »
ten dollars

8 Analyst Stocks Under $10 With Major Upside Calls

Volatility is back, with two weeks in a row of big sell-offs followed by big gains. What this means is that investors and traders remain more than eager to find stocks ...
Read Full Story »
health care

Analyst Still Sees Zogenix Potentially Doubling

Zogenix Inc. (NASDAQ: ZGNX) has been a controversial small cap drug stock, with its abuse-deterrent Zohydro being at front and center. Now that the company has submitted its supplemental new ...
Read Full Story »
Pills

Zogenix CEO Goes on the Offensive

Zogenix Inc. (NASDAQ: ZGNX) has traded like a company that is about to implode. Its highly controversial Zohydro has been getting inquiries into how it was approved for marketing despite ...
Read Full Story »
biotech

Zogenix Tumbles on Fears Its Pain Drug May Lose Out to a Rival

Shares of Zogenix Inc. (NASDAQ: ZGNX) fell as much as 26% on Wednesday after a rival pharmaceutical company said it will seek regulatory approval of a tamper-proof version of Zogenix's ...
Read Full Story »
biotech

Top Pharma and Biotech Stocks to Buy From Key Investor Conference

The Leerink Global Healthcare conference is in full swing, and the reports coming out highlight what some top analysts on Wall Street already suspected. The rich are getting richer. With ...
Read Full Story »
$5

Eight Biotech Stocks Trading Near $5 With Huge Upside Potential

Often when a strong sell-off hits the stock market, the first stocks to go are the big momentum stocks that hedge funds often chase for performance and alpha. Right behind ...
Read Full Story »
buy sell

Ten Top Wall Street Analyst Stocks to Buy Trading Just Above or Below $5

Every quarter we like to review the research at the top firms we cover and look for any new stocks to buy that are priced either slightly above or under ...
Read Full Story »
biotech

Biotech Stocks Under $10 With Huge Upside Potential for 2014

Large cap biotech stocks have seen incredible stock performance over the past few years. The problem for many investors is that many of the key stocks have become so expensive ...
Read Full Story »
ten bucks

Ten Top Stocks Trading Under $10 to Buy for Big 2014 Gains

With less than a week left in what has been the best year for the S&P 500 since 1997, we have reviewed our top Wall Street firms for their stocks ...
Read Full Story »